IP Library Granted Patent US 8,592,183
Granted Patent B2
US 8,592,183 · App. 12/984,822 · Granted Nov 26, 2013

Apparatus and method for sequencing nucleic acid molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,592,183
App. No.
12/984,822
Granted
Nov 26, 2013
Kind
B2
Abstract

The sequence of a target polynucleotide can be determined by: (i) contacting the target polynucleotide with a polymerase enzyme and one of the nucleotides A, T(U), G and C under conditions suitable for the polymerase reaction to proceed; (ii) measuring the time taken for the polymerase to bind to and subsequently dissociate from the target polynucleotide, to thereby determine whether the polymerase has incorporated the nucleotide onto the target polynucleotide; (iii) optionally repeating steps (i) and (ii) with additional nucleotides, to thereby identify the sequence of the target polynucleotide.

Claims (16)

1. A method for sequencing a target polynucleotide, comprising:

a. immobilizing the target polynucleotide on a support of an apparatus for sequencing a polynucleotide, comprising:

i. a flow cell comprising a fluid flow path;

ii. a monochromatic laser; and

iii. a total internal reflection microscope,

wherein the support is positioned within the fluid flow path of the flow cell such that, upon immobilization of a target polynucleotide, the target polynucleotide is positioned in a reaction site within at least a portion of the fluid flow path; and wherein the laser is configured to emit an optical beam directed at the reaction site, and wherein a total internal reflection microscope is focused on the reaction site such that a polymerization reaction associated with the target polynucleotide can be monitored over time;

b. contacting the target polynucleotide with a polymerase enzyme and a nucleotide selected from the group consisting of A, T(U), G, and C under conditions suitable for a polymerase reaction to proceed, wherein the nucleotide comprises a removable blocking group;

c. observing the interaction of the polymerase enzyme and the nucleotide with the target polynucleotide;

d. determining whether the polymerase has incorporated the nucleotide onto the primer sequence; and

e. repeating steps (b)-(d) one or more times, thereby identifying the sequence of the target polynucleotide.

2. The method of claim 1 , wherein unbound nucleotides are removed from the reaction site prior to step (c).

3. The method of claim 1 , wherein the solid support further comprises one or more target polynucleotides immobilized thereon.

4. The method of claim 1 , wherein the solid support further comprises one or more immobilized primer sequences that are complementary to the target polynucleotide.

5. The method of claim 1 , wherein the apparatus is configured to monitor the polymerization reaction by monitoring changes in fluorescent signal intensity over time.

6. The method of claim 1 , wherein the removable blocking group comprises a 5′ blocking group.

7. The method of claim 1 , wherein the removable blocking group comprises a radiation labile blocking group.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →